Selskabets formål er at producere Cannabis til medicinsk brug.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2022 | -9.2 mio. | -39.7 mio. | 39.6 mio. | 15.5 mio. | 16 | |
CVR: 39015684
Secondary names: Medican Pharma A/S, Remedium A/S
Company placed under bankruptcy proceedings
Compared to 130 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
companydata.dk